The Wegovy injectable is approved for weight loss, cardiovascular risk reduction and MASH, but the tablet does not have marketing authorization for MASH
In January 2024, the FDA proposed a rule that would prevent BPC-157 from being used in compounding, classifying it alongside other peptides that lack adequate safety and efficacy data for compounded use 3
2.2 GLP-1R and tau protein hyperphosphorylation Hyperphosphorylated tau is a major component of intracellular neurofibrillary tangles (NFTs), which, together with amyloid plaques, are a distinguishing marker of AD (Tracy et al., 2022
With GLP-1 medications like semaglutide and tirzepatide, results are usually noticeable within the first few weeks, with continued improvements over time when combined with healthy lifestyle habits
8 Epidemiologists can better estimate the size of the eligible population (using BMI and lab criteria instead of diagnosis codes) and understand how treatment patterns evolve over years
The bacteria impacts the production of mucus in the stomach, thereby making it more susceptible to damage from digestive acid and peptic ulcers
